Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:activities |
broad spectrum
inhibits DNA gyrase |
| gptkbp:appointed_by |
oral tablet
intravenous injection |
| gptkbp:approves |
gptkb:1987
gptkb:FDA |
| gptkbp:brand |
gptkb:Cipro
|
| gptkbp:contraindication |
gptkb:Insurance_Company
hypokalemia renal impairment tendon disorders hypomagnesemia liver impairment seizure disorders |
| gptkbp:developed_by |
gptkb:Bayer_AG
|
| gptkbp:dosage_form |
500 mg
1000 mg 250 mg 750 mg |
| gptkbp:excretion |
urine
|
| gptkbp:form |
gptkb:sneaker
ear drops ophthalmic ointment |
| https://www.w3.org/2000/01/rdf-schema#label |
ciprofloxacin
|
| gptkbp:ingredients |
C17 H18 F N3 O3
|
| gptkbp:interacts_with |
gptkb:theophylline
gptkb:warfarin antacids |
| gptkbp:is_atype_of |
J01 M A02
|
| gptkbp:is_available_on |
generic drug
|
| gptkbp:is_effective_against |
fungal infections
viral infections |
| gptkbp:is_used_for |
bacterial infections
|
| gptkbp:lifespan |
4 hours
|
| gptkbp:pharmacokinetics |
well absorbed orally
|
| gptkbp:side_effect |
dizziness
nausea diarrhea photosensitivity tendon rupture hypersensitivity reactions QT prolongation CNS effects |
| gptkbp:suitable_for |
gptkb:Person
pregnant women breastfeeding women |
| gptkbp:type_of |
85721-33-1
|
| gptkbp:used_in |
respiratory infections
skin infections urinary tract infections gastrointestinal infections bone infections |
| gptkbp:bfsParent |
gptkb:Cipro
gptkb:mythological_figure |
| gptkbp:bfsLayer |
3
|